STRUCTURED WARRANTS ANNOUNCEMENT : INITIAL OFFERING
DPHARMA-C7: CW DUOPHARMA BIOTECH BERHAD (CIMB) |
Type | Announcement |
Subject | STRUCTURED WARRANTS ANNOUNCEMENT INITIAL OFFERING |
Description | CIMB BANK BERHAD ("CIMB BANK") PROPOSED ISSUE OF UP TO 150,000,000 EUROPEAN STYLE NON-COLLATERALISED CASH-SETTLED CALL WARRANTS OVER ORDINARY SHARES OF DUOPHARMA BIOTECH BERHAD ("DPHARMA") ("DPHARMA-C7") |
We are pleased to announce the proposed issue by CIMB Bank of up to 150,000,000 European-style non-collateralised cash-settled call warrants over ordinary shares in DPHARMA.
The DPHARMA-C7 is constituted by the Deed Poll dated 18 April 2022 executed by us, as supplemented from time to time. The DPHARMA-C7 is subject to the terms and conditions of the Base Prospectus dated 22 April 2022, the First Supplementary Base Prospectus dated 3 June 2022, the Second Supplementary Base Prospectus dated 19 July 2022, the Third Supplementary Base Prospectus dated 6 September 2022 and the Term Sheet for the DPHARMA-C7 dated 28 November 2022.
The DPHARMA-C7 is to be listed on the Structured Warrants Board of Bursa Malaysia Securities Berhad. A summary of the principal terms of the DPHARMA-C7 is set out in the attachment.
This announcement is dated 29 November 2022.
|
Please refer attachment below.
Announcement Info
Company Name | DPHARMA-C7: CW DUOPHARMA BIOTECH BERHAD (CIMB) |
Stock Name | DPHARMA-C7 |
Date Announced | 29 Nov 2022 |
Category | General Announcement for PLC |
Reference Number | GA1-28112022-00019 |